Sun, Jan 25, 2015, 10:11 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Momenta Pharmaceuticals Inc. Message Board

  • rybovich58 rybovich58 Jan 26, 2012 11:50 AM Flag

    Not "a final decision"

    The court’s action would let Amphastar and Watson enter the market for generic Lovenox, Michael Tong, an analyst with Wells Fargo Securities in New York, said in a note to clients. Parsippany, New Jersey-based Watson would have to begin sales knowing there’s a risk it could later lose the case, Tong said.

    “A launch is not necessarily imminent,” he said.

    Momenta and Novartis AG (NOVN)’s Sandoz unit already sell a copy of Lovenox, and Momenta won an order in October that prevented Amphastar and Watson from marketing their version. The appeal of that decision was heard by on Jan. 24. The resulting “order does not represent a final decision with respect to the merits of the pending appeal,” the court said in yesterday’s docket.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
10.63-0.56(-5.00%)Jan 23 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.